Development and comparison of two nonradioactive kinase assays for I kappa B kinase

Analytical Biochemistry

Volumn 326, Issue 1, 2004, Pages 106-113

  Sadler, Tammy M ^a   Achilleos, Maria ^a   Ragunathan, Shoba ^a   Pitkin, Adam ^a   LaRocque, James ^a   Morin, John ^a   Annable, Rebecca ^a,b   Greenberger, Lee M ^a   Frost, Philip ^a   Zhang, Yixian ^a  

^a WYETH RESEARCH   (United States)

^b ROCKEFELLER UNIVERSITY   (United States)

Author keywords

IKK ; Inhibitor; Kinase; NF B; Nonradioactive

Indexed keywords

ENERGY TRANSFER; ENZYME INHIBITION; FLUORESCENCE; TRANSCRIPTION;

HIGH THROUGHPUT SCREENING; INHIBITOR; INHIBITORY PROTEINS; KINASE; LANTHANIDE FLUORESCENCE; MICHAELIS CONSTANTS; NONRADIOACTIVE; TIME-RESOLVED FLUORESCENCE;

WASTE MANAGEMENT;

ADENOSINE TRIPHOSPHATE; I KAPPA B KINASE; K 252A; LANTHANIDE; PHOSPHOTRANSFERASE; PHOSPHOTRANSFERASE INHIBITOR;

ACCURACY; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DISSOCIATION CONSTANT; ENERGY TRANSFER; ENZYME ACTIVITY; ENZYME ANALYSIS; ENZYME ASSAY; FLUORESCENCE; HUMAN; IC 50; IMMUNOASSAY; MICHAEL ADDITION; MOLECULAR MECHANICS; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RADIOACTIVITY; REACTION TIME; VALIDATION PROCESS;

EID: 10744221154     PISSN: 00032697     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ab.2003.11.021     Document Type: Article

References (26)

1. Baldwin A.S. THE NF-kappa-B and I-kappa-B proteins - new discoveries and insights [Review]. Annu. Rev. Immunol. 14:1996;649-683.
2. Barnes P.J., Karin M. Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases. N. Engl. J. Med. 336:1997;1066-1071.
3. Baldwin A.S. Control of oncogenesis and cancer therapy resistance by the transcription factor NF-kappaB. J. Clin. Invest. 107:2001;241-246.
4. Yamamoto Y., Gaynor R.B. Therapeutic potential of inhibition of the NF-kappaB pathway in the treatment of inflammation and cancer. J. Clin. Invest. 107:2001;135-142.
5. Lin X., Mu Y., Cunningham E.T. Jr., Marcu K.B., Geleziunas R., Greene W.C. Molecular determinants of NF-kappaB-inducing kinase action. Mol. Cell. Biol. 18:1998;5899-5907.
6. Woronicz J.D., Gao X., Cao Z., Rothe M., Goeddel D.V. IkappaB kinase-beta: NF-kappaB activation and complex formation with IkappaB kinase-alpha and NIK. Science. 278:1997;866-869.
7. Nemoto S., DiDonato J.A., Lin A. Coordinate regulation of IkappaB kinases by mitogen-activated protein kinase kinase kinase 1 and NF-kappaB-inducing kinase. Mol. Cell. Biol. 18:1998;7336-7343.
8. Lee Frank S., Peters Robert T., Dang Luan C., Maniatis T. MEKK1 activates both IkappaB kinase alpha and IkappaB kinase beta. Proc. Natl. Acad. Sci. USA. 95:1998;9319-9324.
9. Zhao M., New L., Kravchenko Vladimir V., Kato Y., Gram H., Di Padova F., Olson Eric N., Ulevitch Richard J., Han J. Regulation of the MEF2 family of transcription factors by p38. Mol. Cell. Biol. 19:1999;21-30.
10. Romashkova J.A., Makarov S.S. NF-kappaB is a target of AKT in anti-apoptotic PDGF signalling. Nature. 401:1999;86-90.
11. Ozes O.N., Mayo L.D., Gustin J.A., Pfeffer S.R., Pfeffer L.M., Donner D.B. NF-kappaB activation by tumour necrosis factor requires the Akt serine-threonine kinase. Nature. 401:1999;82-85.
12. Takeda K., Takeuchi O., Tsujimura T., Itami S., Adachi O., Kawai T., Sanjo H., Yoshikawa K., Terada N., Akira S. Limb and skin abnormalities in mice lacking IKKalpha. Science. 284:1999;313-316.
13. Li Q., Lu Q., Hwang J.Y., Buscher D., Lee K.F., Izpisua-Belmonte J.C., Verma I.M. IKK1-deficient mice exhibit abnormal development of skin and skeleton. Genes Dev. 13:1999;1322-1328.
14. Li Q., Van Antwerp D., Mercurio F., Lee K.F., Verma I.M. Severe liver degeneration in mice lacking the IkappaB kinase 2 gene. Science. 284:1999;321-325.
15. Li Z.W., Chu W., Hu Y., Delhase M., Deerinck T., Ellisman M., Johnson R., Karin M. The IKKbeta subunit of IkappaB kinase (IKK) is essential for nuclear factor kappaB activation and prevention of apoptosis. J. Exp. Med. 189:1999;1839-1845.
16. Karin M., Ben-Neriah Y. Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity. Annu. Rev. Immunol. 18:2000;621-663.
17. Wisniewski D., LoGrasso P., Calaycay J., Marcy A. Assay for IkappaB kinases using an in vivo biotinylated IkappaB protein substrate. Anal. Biochem. 274:1999;220-228.
18. Janes K.A., Albeck J.G., Peng L.X., Sorger P.K., Lauffenburger D.A., Yaffe M.B. A high-throughput quantitative multiplex kinase assay for monitoring information flow in signaling networks: application to sepsis-apoptosis. Mol. Cell. Proteomics. 2:2003;463-473.
19. Huynh Q.K., Boddupalli H., Rouw S.A., Koboldt C.M., Hall T., Sommers C., Hauser S.D., Pierce J.L., Combs R.G., Reitz B.A., Diaz-Collier J.A., Weinberg R.A., Hood B.L., Kilpatrick B.F., Tripp C.S. Characterization of the recombinant IKK1/IKK2 heterodimer. Mechanisms regulating kinase activity. J. Biol. Chem. 275:2000;25883-25891.
20. Mercurio F., Murray Brion W., Shevchenko A., Bennett Brydon L., Young David B., Li Jian W., Pascual G., Motiwala A., Zhu H., Mann M., Manning Anthony M. IkappaB kinase (IKK)-associated protein 1, a common component of the heterogeneous IKK complex. Mol. Cell. Biol. 19:1999;1526-1538.
21. Li J., Peet Gregory W., Pullen Steven S., Schembri-King J., Warren Thomas C., Marcu Kenneth B., Kehry Marilyn R., Barton R., Jakes S. Recombinant IkappaB kinases alpha and alpha are direct kinases of IkappaBalpha. J. Biol. Chem. 273:1998;30736-30741.
22. Pierce J.W., Schoenleber R., Jesmok G., Best J., Moore S.A., Collins T., Gerritsen M.E. Novel inhibitors of cytokine-induced IkappaBalpha phosphorylation and endothelial cell adhesion molecule expression show anti-inflammatory effects in vivo. J. Biol. Chem. 272:1997;21096-21103.
23. Hehner S.P., Hofmann T.G., Droge W., Schmitz M.L., Fiebich Bernd L., Lieb K., Engels S., Heinrich M. The antiinflammatory sesquiterpene lactone parthenolide inhibits NF-kappa B by targeting the I kappa B kinase complex Inhibition of LPS-induced p42/44 MAP kinase activation and iNOS/NO synthesis by parthenolide in rat primary microglial cells. J. Immunol. 163:1999;5617-5623.
24. Kwok B.H.B., Koh B., Ndubuisi M.I., Elofsson M., Crews C.M. The anti-inflammatory natural product parthenolide from the medicinal herb Feverfew directly binds to and inhibits I kappa B kinase. Chem. Biol. 8:2001;759-766.
25. Peet Gregory W., Li J. IkappaB kinases alpha and beta show a random sequential kinetic mechanism and are inhibited by staurosporine and quercetin. J. Biol. Chem. 274:1999;32655-32661.
26. Natarajan K., Manna S.K., Chaturvedi M.M., Aggarwal B.B. Protein tyrosine kinase inhibitors block tumor necrosis factor-induced activation of nuclear factor-kappaB, degradation of IkappaBalpha, nuclear translocation of p65, and subsequent gene expression. Arch. Biochem. Biophys. 352:1998;59-70.